in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Fine Chemicals: Siegfried Lifted by API Market, Pulled Down by Generics
March 18, 2008 | Alex Scott
Fine chemicals group Siegfried (Zofingen, Switzerland) says in the past few months pharmaceutical companies have begun to show an increasing interest in undertaking exclusive synthesis projects at the company. “The reason for this interest is seen in the comprehensive restructuring programs launched by about two-thirds of the large, globally active pharma companies, resulting in the elimination of excess chemical capacity,” Siegfried says. That perceived change in the market has already led to an increase in exclusive synthesis activity at Siegfried...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee